Fennec Pharmaceuticals, Inc.
(Toronto Stock Exchange : FENC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -5.13%68.931.0%$1428.71m
BIIBBiogen, Inc. -0.44%308.711.5%$631.84m
REGNRegeneron Pharmaceuticals, Inc. 0.95%435.692.6%$529.95m
AMGNAmgen, Inc. -2.49%198.431.3%$513.30m
ILMNIllumina, Inc. 0.10%260.193.5%$396.24m
VRTXVertex Pharmaceuticals, Inc. -0.90%221.301.9%$345.30m
MRNAModerna, Inc. -11.32%23.200.0%$335.20m
ALXNAlexion Pharmaceuticals, Inc. 0.67%92.712.0%$222.19m
CODXCo-Diagnostics, Inc. -14.16%13.700.0%$212.35m
AAgilent Technologies, Inc. -1.49%76.281.6%$167.25m
EXASEXACT Sciences Corp. -0.21%80.6524.0%$163.27m
BMRNBioMarin Pharmaceutical, Inc. -0.07%89.764.3%$114.66m
SGENSeattle Genetics, Inc. 3.24%111.826.1%$109.33m
INCYIncyte Corp. -1.69%74.562.5%$108.52m
NVAXNovavax, Inc. 30.51%15.40184.0%$85.79m

Company Profile

Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.